Brief: Omega Fund V LP Reports 3.9% Stake In Nuvation Bio As Of Sept 4, 2024 Versus 6.9% As Of April 5, 2022 - SEC Filing
18/10/2024 21:47
Oct 18 (Reuters) - Nuvation Bio Inc NUVB.N :
* OMEGA FUND V LP REPORTS 3.9% STAKE IN NUVATION BIO AS OF
SEPT 4,
2024 VERSUS 6.9% AS OF APRIL 5, 2022 - SEC FILING
Source text for Eikon: ID:n0001193125-24-239642
Further company coverage: NUVB.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth